Literature DB >> 12657415

Serotonin-related tryptophan in children with insulin-dependent diabetes.

Rocío Herrera1, Gabriel Manjarrez, Elisa Nishimura, Jorge Hernandez.   

Abstract

In the course of the present research in school children with insulin-dependent diabetes mellitus, we observed that the free fraction of L-tryptophan, the free fraction of L-tryptophan/total L-tryptophan, and the free fraction of L-tryptophan/neutral amino acids ratios, are significantly reduced. The decrease of free fraction of L-tryptophan in plasma with a concomitant decrease of the free fraction of L-tryptophan/neutral amino acids ratio suggest a decrease in the transport of the precursor amino acid to the brain and in the serotonin synthesis rate, similar to that observed in diabetic animals. This finding may be of relevance in the pathophysiology and in the clinical picture, which could be related to an alteration of serotonin metabolism and neurotransmission in the brain and may be possibly related to neuropsychiatric disorders in diabetic school children. Thus we propose that the free fraction of L-tryptophan and the free fraction of L-tryptophan/neutral amino acids ratios may be clinically useful as indicators of brain serotonergic activity in these patients. In our laboratory, we are currently obtaining additional data on the functional role of the brain serotonergic system in humans to further support the relevance of our results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657415     DOI: 10.1016/s0887-8994(02)00462-9

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

Review 1.  Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link.

Authors:  D J Korczak; S Pereira; K Koulajian; A Matejcek; A Giacca
Journal:  Diabetologia       Date:  2011-07-26       Impact factor: 10.122

2.  Tropisetron modulates peripheral and central serotonin/insulin levels via insulin and nuclear factor kappa B/receptor for advanced glycation end products signalling to regulate type-2 diabetes in rats.

Authors:  Reem Ali Mohamed; Omneya Galal; Ahmed Refaat Mohammed; Hanan Salah El-Abhar
Journal:  RSC Adv       Date:  2018-03-27       Impact factor: 4.036

3.  Orally administered tryptophan and experimental type 2 diabetes.

Authors:  M A Tormo; A Romero de Tejada; I Morales; S Paredes; S Sánchez; C Barriga; R Hernández
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

4.  An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology.

Authors:  Leszek A Rybaczyk; Meredith J Bashaw; Dorothy R Pathak; Scott M Moody; Roger M Gilders; Donald L Holzschu
Journal:  BMC Womens Health       Date:  2005-12-20       Impact factor: 2.809

5.  Tryptophan Predicts the Risk for Future Type 2 Diabetes.

Authors:  Tianlu Chen; Xiaojiao Zheng; Xiaojing Ma; Yuqian Bao; Yan Ni; Cheng Hu; Cynthia Rajani; Fengjie Huang; Aihua Zhao; Weiping Jia; Wei Jia
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

6.  Identification of potential plasma biomarkers and metabolic dysfunction for unstable angina pectoris and its complication based on global metabolomics.

Authors:  Juan Wang; Wenjuan Xu; Huihui Zhao; Jianxin Chen; Bin Zhu; Xueli Li; Dong Deng; Jinping Wang; Junjie Liu; Yingting Yu; Hongbin Xiao; Wei Wang
Journal:  Biosci Rep       Date:  2019-03-22       Impact factor: 3.840

7.  Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study.

Authors:  Linda A Gonder-Frederick; John F Zrebiec; Andrea U Bauchowitz; Lee M Ritterband; Joshua C Magee; Daniel J Cox; William L Clarke
Journal:  Diabetes Care       Date:  2009-03-26       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.